2018 Digital Pharma and Life Sciences IQ Survey: The no excuses way to win in a digital world

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.

Overview

PwC’s 11th Anniversary Digital IQ Survey: For health industries, the definition of “digital” differs across subsectors, pointing to uneven progress in digital transformation. While some say digital is synonymous with IT, others have advanced enough to see digital as more than a technology, but a mindset.

Pharma companies lack a consistent view of what “digital” is

Digital has come to mean having an organizational mindset that embraces constant innovation, flat decision making, and the integration of technology into all phases of the business.

However, organizations are not aligned on the definition and purpose of digital, this results in incoherent digital initiatives and governance.

Digital efforts have yet to pay off in any meaningful way

While Pharma respondents expect the most value in how they innovate products and services, less than one-third say their investments to date have met or exceeded their expectations in those areas.

Pharma executives have identified key goals for digital transformation

Contact us

Jamie Gunsior

Principal, Digital Healthcare Leader, PwC US

Omar Chane

Principal, PwC US

Tim Pantello

PLS Lead, PwC US

Follow us